• |
  • |
  • |
  • |
Donate

Product

LEND: Clinical experiences with sodium thiosulfate (STS) for hearing protection in children treated with cisplatin

Center:
Fiscal Year:
2025
Contact Information:
Product Description:
Presentation about clinical cancer trials with STS for hearing protection in children treated with cisplatin, the status of FDA and EMA approval, and clinical experiences with STS.
Keyword(s):
hearing loss, children, cisplatin, ototoxicity, rehabilitation
Product/Publication Type(s):
Conference presentations and posters presented
Target Audience:
Professionals, Policymakers, Students
Alternative Format:
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A